Homepage - Sol-Gel

Dermatology company with two FDA approved products marketed by Galderma in the US

Advanced pipeline of products for the treatment of rare skin diseases

Previous

Next

TWYNEO^® is now available in the U.S. for the treatment of Acne Vulgaris

EPSOLAY® is now available in the U.S. for the treatment of Inflammatory Lesions of Rosacea

Our Product Pipeline

Sol-Gel is developing a diverse pipeline of innovative topical skin medications